Indian Insulin Exporters: Complete Supplier Ranking with Market Share — 384 Manufacturers (2026) — TransData Nexus

Q: Who is the largest insulin buyer importing from India?

AYUSH PHARMA S.A DE C.V. (MEXICO) is the largest insulin importer from India with a 10.1% market share and import value of $7.7M.

Q: How many insulin buyers import from India?

There are 384 active insulin buyers importing from India, with a combined import market of $76.0M across 2,532 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top insulin buyers from India?

The top 5 insulin buyers — AYUSH PHARMA S.A DE C.V., BERLIN PHARMACEUTICALS INDUSTRY CO., BJC HEALTHCARE COMPANY LIMITED, BERLIN PHARMACEUTICALS INDUSTRY CO, COMMERCIAL BANK OF ETHIOPIA — together control 39.6% of total insulin import value from India.

Suresh Sormare

Insulin

India Pharmaceutical Trade Intelligence

$76.0M188 Suppliers111 CountriesHS 30043110

ExportsIndia → THAILAND28.6%India → MEXICO19.2%

ImportsDENMARK → India$358.7B BRAZIL → India$149.3B

#1 Supplier: WOCKHARDT LIMITED

Market Analysis: Top Importing Countries & Their Importers

1Thailand

Thailand emerges as the first largest importing country, achieving a total trade value of $21.7M through 339 shipments. This represents a market share of 28.6% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Thailand has a diverse importer base, with their top importers including:

• BERLIN PHARMACEUTICALS INDUSTRY CO. - $6.2M (28.6% of country's total business)

• BJC HEALTHCARE COMPANY LIMITED - $6.1M (28.0% of country's total business)

• BERLIN PHARMACEUTICALS INDUSTRY CO - $5.2M (23.9% of country's total business)

• BERLIN PHARMACEUTICALS INDUSTRY CO, - $2.0M (9.3% of country's total business)

Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $64.1K, indicating premium pricing strategy compared to the market average of $30.0K.

Thailand is a key market for Insulin imports, representing 28.6% of total trade value.

Primary Market

Secondary Market

2Mexico

Buyer Segment Analysis

TransData Nexus Insulin buyer market intelligence

1Buyer Segment Analysis

The analysis of insulin imports from India reveals a diverse buyer landscape, encompassing several key segments:

Distributors: Entities such as AYUSH PHARMA S.A DE C.V. (Mexico) and DIABETIKA SRL (Dominican Republic) function as intermediaries, procuring insulin in bulk to supply to various healthcare providers and pharmacies within their respective regions. Their purchasing patterns typically involve large, periodic orders to maintain a steady supply chain.

Hospital Groups: Organizations like BJC HEALTHCARE COMPANY LIMITED (Thailand) represent hospital networks that import insulin directly to meet the needs of their inpatient and outpatient services. Their procurement is characterized by consistent, scheduled orders aligned with patient demand and treatment protocols.

Government Procurement: The COMMERCIAL BANK OF ETHIOPIA (Ethiopia) likely acts on behalf of government health initiatives, facilitating large-scale purchases of insulin for national distribution through public healthcare facilities. This segment's buying behavior is often driven by public health policies and tender-based purchasing systems.

Retail Chains: Entities such as INNODRIVE GROUP S.A DE CV (Mexico) may represent pharmacy chains that import insulin to stock their retail outlets, ensuring availability for consumers. Their order patterns are influenced by consumer demand and inventory turnover rates.

Country-Specific Import Regulations

TransData Nexus Insulin buyer market intelligence

1Country-Specific Import Regulations

Navigating the import regulations for insulin in the top importing countries is essential for market entry and compliance. Below is an overview for each:

Thailand

1. Drug Regulatory Authority: Food and Drug Administration (FDA) Thailand.

2. Import Registration Process: Importers must obtain an import permit from the FDA Thailand. This involves submitting detailed product information, including composition, manufacturing process, and quality control measures.

3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and the FDA's review workload.

4. Import Tariff/Duty for HS 30043110: Specific tariff rates should be confirmed with the Thai Customs Department, as they are subject to change and may vary based on trade agreements.

Mexico

1. Drug Regulatory Authority: Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).

2. Import Registration Process: Importers are required to register the product with COFEPRIS, providing comprehensive documentation on the product's safety, efficacy, and quality.

3. Estimated Timeline for Registration: The registration process typically ranges from 6 to 12 months, contingent upon the complexity of the product and the regulatory body's assessment.

4. Import Tariff/Duty for HS 30043110: Tariff rates can vary; it is advisable to consult the Mexican Customs Authority for the most current information.

Ethiopia

1. Drug Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).

2. Import Registration Process: Importers must register pharmaceutical products with the EFDA, submitting dossiers that include clinical data, manufacturing details, and labeling information.

Demand Drivers & Market Opportunity

TransData Nexus Insulin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for insulin in importing countries is driven by several key factors:

Disease Prevalence: The global rise in diabetes cases, particularly in low- and middle-income countries (LMICs), significantly increases the need for insulin. (who.int)

Government Healthcare Programs: Many governments are implementing initiatives to improve diabetes care, including subsidizing insulin costs and enhancing healthcare infrastructure.

Universal Health Coverage Expansion: Efforts to achieve universal health coverage are leading to increased access to essential medicines, including insulin, thereby boosting demand.

WHO Essential Medicines List Procurement: The inclusion of insulin in the WHO Essential Medicines List encourages countries to prioritize its procurement, ensuring availability in public health systems.

Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of insulin, aiming to secure lower prices and ensure a consistent supply for their populations.

Common Questions — Insulin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest insulin buyer importing from India?

Based on import volume and value, AYUSH PHARMA S.A DE C.V. (MEXICO) leads with $7.7M in imports and a 10.1% market share — the highest of any single insulin importer. BERLIN PHARMACEUTICALS INDUSTRY CO. (THAILAND) and BJC HEALTHCARE COMPANY LIMITED (THAILAND) are the next largest buyers.

QHow many companies buy insulin from India?

There are 384 active insulin buyers importing from India, with a combined market of $76.0M across 2,532 shipments to 111 countries. The top 5 buyers hold 39.6% of total import value, while the remaining 379 buyers handle the other 60.4%.

QWhich countries import the most insulin from India?

The top importing countries for insulin from India are Thailand (28.6%), Mexico (19.2%), Ethiopia (6.5%), Pakistan (6.0%), Dominican Republic (4.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of insulin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for insulin from India?

The average import transaction value for insulin from India is $30.0K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Insulin buyer market intelligence

1Buyer Segment Analysis

The analysis of insulin imports from India reveals a diverse buyer landscape, encompassing several key segments:

Distributors: Entities such as AYUSH PHARMA S.A DE C.V. (Mexico) and DIABETIKA SRL (Dominican Republic) function as intermediaries, procuring insulin in bulk to supply to various healthcare providers and pharmacies within their respective regions. Their purchasing patterns typically involve large, periodic orders to maintain a steady supply chain.

Hospital Groups: Organizations like BJC HEALTHCARE COMPANY LIMITED (Thailand) represent hospital networks that import insulin directly to meet the needs of their inpatient and outpatient services. Their procurement is characterized by consistent, scheduled orders aligned with patient demand and treatment protocols.

Government Procurement: The COMMERCIAL BANK OF ETHIOPIA (Ethiopia) likely acts on behalf of government health initiatives, facilitating large-scale purchases of insulin for national distribution through public healthcare facilities. This segment's buying behavior is often driven by public health policies and tender-based purchasing systems.

Retail Chains: Entities such as INNODRIVE GROUP S.A DE CV (Mexico) may represent pharmacy chains that import insulin to stock their retail outlets, ensuring availability for consumers. Their order patterns are influenced by consumer demand and inventory turnover rates.

Country-Specific Import Regulations

TransData Nexus Insulin buyer market intelligence

1Country-Specific Import Regulations

Navigating the import regulations for insulin in the top importing countries is essential for market entry and compliance. Below is an overview for each:

Thailand

1. Drug Regulatory Authority: Food and Drug Administration (FDA) Thailand.

3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and the FDA's review workload.

4. Import Tariff/Duty for HS 30043110: Specific tariff rates should be confirmed with the Thai Customs Department, as they are subject to change and may vary based on trade agreements.

Mexico

1. Drug Regulatory Authority: Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).

2. Import Registration Process: Importers are required to register the product with COFEPRIS, providing comprehensive documentation on the product's safety, efficacy, and quality.

3. Estimated Timeline for Registration: The registration process typically ranges from 6 to 12 months, contingent upon the complexity of the product and the regulatory body's assessment.

4. Import Tariff/Duty for HS 30043110: Tariff rates can vary; it is advisable to consult the Mexican Customs Authority for the most current information.

Ethiopia

1. Drug Regulatory Authority: Ethiopian Food and Drug Authority (EFDA).

2. Import Registration Process: Importers must register pharmaceutical products with the EFDA, submitting dossiers that include clinical data, manufacturing details, and labeling information.

Demand Drivers & Market Opportunity

TransData Nexus Insulin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for insulin in importing countries is driven by several key factors:

Disease Prevalence: The global rise in diabetes cases, particularly in low- and middle-income countries (LMICs), significantly increases the need for insulin. (who.int)

Government Healthcare Programs: Many governments are implementing initiatives to improve diabetes care, including subsidizing insulin costs and enhancing healthcare infrastructure.

Universal Health Coverage Expansion: Efforts to achieve universal health coverage are leading to increased access to essential medicines, including insulin, thereby boosting demand.

WHO Essential Medicines List Procurement: The inclusion of insulin in the WHO Essential Medicines List encourages countries to prioritize its procurement, ensuring availability in public health systems.

Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of insulin, aiming to secure lower prices and ensure a consistent supply for their populations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Insulin

Insulin

Who Buys Insulin from India — 384 Importers Behind a $76.0M Market

Top Insulin Importers — Ranked by Import Value

Top Insulin Buyers & Importers

Related Analysis

Need Details?

Insulin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Insulin — and from which countries?

Insulin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Thailand

2Mexico

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Insulin Buyers & Importers

QWho is the largest insulin buyer importing from India?

QHow many companies buy insulin from India?

QWhich countries import the most insulin from India?

QWhat is the average import order value for insulin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Ethiopia

4Pakistan

5Dominican Republic

Analysis Methodology